0003-3170
0003-3170
S0003-31702020000500004
10.20960/angiologia.00138
Spain
00
10
2020
00
10
2020
72
5
240
252
[
1993
328
1167-72
]
[
2017
66
2
2
]
[
2014
383
9921
9921
963-9
]
[
2007
45
443-50
]
[
2006
44
1-8
]
[
2009
85
268-73
]
[
2007
188
57-62
]
[
2013
45
]
[
2016
31
1291-302
]
[
2019
57
8-93
]
[
2015
67
Supl.1
Supl.1
7-56
]
[
2016
57
830-8
]
[
2010
52
5-12
]
[
2012
256
688-95
]
[
2009
249
510-5
]
[
2006
31
339-44
]
[
2007
15
197-200
]
[
IMPROVE trial investigators
2013
101
216-24
]
[
2018
67
1-75
]
[
2017
141-9
]
[
IMPROVE Trial Investigators
2015
36
206-9
]
[
IMPROVE Trial Investigators
2017
359
]
[
2015
50
3
3
297-302
]
[
2017
]
[
2008
47
214-21
]
[
IMPROVE Trial Investigators
2018
55
625-32
]
[
NICE guidelines
2020
]
[
2016
52
597-603
]
[
2013
30
6
6
270-382
]
[
2002
23
528-36
]
[
2017
95
1
1
38-43
]
[
IMPROVE trial investigators
2014
348
7661
]
[
2015
61
304-8
]
[
2010
51
9-17
]
[
2015
38
1425-37
]
[
2015
79
6
6
930-6
]
[
2016
57
233-41
]
[
2011
42
775-86
]
[
IMPROVE Trial Investigators
2018
55
625-32
]
[
2009
16
3
3
295-301
]
[
2012
20
61-4
]
[
2016
19
]
[
2016
64
1609-16
]
[
2018
68
991-7
]
[
2016
63
49-54
]
[
2011
35
1662-70
]
[
2016
51
802-9
]
[
2019
]
[
American College of chest physicians antithrombotic therapy and prevention of thrombosis panel
2012
141
7S-47S
]
[
2013
39
1190-206
]
[
2009
50
1-7
]
[
2016
52
158-65
]
[
2005
42
1047-51
]
[
2014
59
829-42
]
[
2014
55
179-92
]
[
2017
41
152-61
]
[
2020
62
83-91
]
[
2019
71
6
6
217-25
]